发明授权
US06630459B2 Pharmaceutical compositions comprising poly-&bgr;-1→4-N-acetylglucosamine
失效
包含聚-β-1→4-N-乙酰葡糖胺的药物组合物
- 专利标题: Pharmaceutical compositions comprising poly-&bgr;-1→4-N-acetylglucosamine
- 专利标题(中): 包含聚-β-1→4-N-乙酰葡糖胺的药物组合物
-
申请号: US10005142申请日: 2001-12-05
-
公开(公告)号: US06630459B2公开(公告)日: 2003-10-07
- 发明人: John N. Vournakis , Sergio Finkielsztein , Ernest R. Pariser , Mike Helton
- 申请人: John N. Vournakis , Sergio Finkielsztein , Ernest R. Pariser , Mike Helton
- 主分类号: A01N4304
- IPC分类号: A01N4304
摘要:
The present invention relates to a purified, easily produced poly-&bgr;-1→4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are attached in a &bgr;-1→4 conformation, and which is free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. In addition, derivatives and reformulations of p-GlcNAc are described. The present invention further relates to methods for the purification of the p-GlcNAc of the invention from microalgae, preferably diatom, starting sources. Still further, the invention relates to methods for the derivatization and reformulation of the p-GlcNAc. Additionally, the present invention relates to the uses of pure p-GlcNAc, its derivatives, and/or its reformulations.
公开/授权文献
信息查询